Encompass Health Home Health Of Western Idaho | |
435 S Whitley Dr, Fruitland, Idaho 83619 | |
(208) 452-4972 | |
Name | Encompass Health Home Health Of Western Idaho |
---|---|
Location | 435 S Whitley Dr, Fruitland, Idaho |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 137113 |
Ownership Type | Proprietary |
Service Area Zip Codes | 83610, 83612, 83617, 83619, 83632, 83636, 83643, 83645, 83655, 83660, 83661, 83672, 97901, 97906, 97907, 97913, 97914, 97918 |
NPI Number | 1003916230 |
Organization Name | ORION HOMECARE, LLC |
Doing Business As | ENHABIT HOME HEALTH OF WESTERN IDAHO |
Address | 435 S Whitley Dr, Fruitland, ID 83619 |
Phone Number | 208-452-4972 |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
Quality Rating: |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 97.9 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
How often the home health team checked patients for depression | 99.2 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 71.4 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 78.7 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.2 | 96.4 |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 75.2 | 79.6 |
How often patients got better at getting in and out of bed | 78.4 | 81.1 |
How often patients got better at bathing | 81.9 | 82.3 |
How often patients’ breathing improved | 79.7 | 82.8 |
How often patients’ wounds improved or healed after an operation | 91.2 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 78.4 | 75 |
How often home health patients had to be admitted to the hospital | 14.5 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 18.8 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 95.7 | 94 |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
The patient survey data of Encompass Health Home Health Of Western Idaho is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 85 | 88 |
Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 78 | 78 |
News Archive
The Senate Health, Education, Labor and Pensions Committee on Wednesday by voice vote approved President Bush's nomination of acting FDA Commissioner Andrew von Eschenbach to permanently head the agency, but potential holds to a full Senate vote on the nomination remain, the New York Times reports (Harris, New York Times, 9/21). Sen. Jim DeMint (R-S.C.)
Military families having children with autism have filed a class action lawsuit against the Department of Defense, alleging that the DoD and its health benefits division, TRICARE, have wrongfully refused to provide insurance coverage for applied behavior analysis therapy. In a dramatic new development, the Department of Defense has vacated its prior policy of denying payment for ABA therapy for autistic children of military families, but it is still refusing to pay for such claims.
Genentech, a member of the Roche Group, today announced it has entered into a definitive agreement to acquire Seragon Pharmaceuticals, Inc., a privately held biotechnology company based in San Diego, California.
New findings from a large European study of patients in 18 countries, including the UK, show that while many patients are able to reduce their risk through taking statins, those at the highest risk of cardiovascular events may benefit from combinations of lipid-lowering therapies.
Filoviruses like Ebola "edit" genetic material as they invade their hosts, according to a study published this week in mBio, the online open-access journal of the American Society for Microbiology.
› Verified 8 days ago
Canyon Home Care & Hospice Location: 929 Nw 16th Street, Fruitland, Idaho 83619 Ratings: Phone: (208) 642-1838 | |
Encompass Health Home Health Of Western Idaho Location: 435 S Whitley Dr, Fruitland, Idaho 83619 Ratings: Phone: (208) 452-4972 |